Extraneal and Dial drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Extraneal (icodextrin) and Dial (hexachlorophene). Common drug interactions include pneumoperitoneum among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Extraneal and Dial. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Extraneal?

Extraneal has active ingredients of icodextrin. eHealthMe is studying from 32,994 Extraneal users. Check the latest studies of Extraneal.

What is Dial?

Dial has active ingredients of hexachlorophene. eHealthMe is studying from 53 Dial users. Check the latest studies of Dial.



On Jul, 13, 2026

17 people who take Extraneal and Dial together, and have interactions are studied.

Extraneal and Dial drug interactions.

What are the common drug interactions of Extraneal and Dial, by gender? *:

female:

  1. Pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity)
  2. Procedural pain
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. General physical health deterioration (weak health status)
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Hypersensitivity
  7. Abdominal distension
  8. Abdominal rigidity
  9. Encephalopathy (functioning of the brain is affected by some agent or condition)
  10. Faecal volume increased

male:

  1. Abdominal pain
  2. Peritoneal cloudy effluent
  3. Cardiac failure
  4. Catheter site infection (infection at the site of insertion)
  5. Cerebral haematoma (collection of blood in brain)
  6. Fall
  7. Head injury
  8. Infarction (obstruction of the blood supply to an organ or region of tissue)
  9. Oxygen saturation decreased
  10. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)

What are the common drug interactions of Extraneal and Dial, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. General physical health deterioration (weak health status)
  3. Monocytosis (an increase in the number of monocytes circulating in the blood)
  4. Peritoneal cloudy effluent
  5. Pyrexia (fever)

30-39:

  1. Abdominal pain
  2. Pain
  3. Pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity)

40-49:

  1. Disease recurrence
  2. Peritoneal cloudy effluent

50-59:

  1. Faecal volume increased
  2. Gait disturbance
  3. Monocytosis (an increase in the number of monocytes circulating in the blood)
  4. Peritoneal cloudy effluent
  5. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  6. Pruritus (severe itching of the skin)

60+:

  1. Anuria (failure of the kidneys to produce urine)
  2. General physical health deterioration (weak health status)
  3. Catheter site infection (infection at the site of insertion)
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Infarction (obstruction of the blood supply to an organ or region of tissue)
  6. Oxygen saturation decreased
  7. Peritoneal cloudy effluent
  8. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. Ultrafiltration Failure: 1 person, 5.88%
  2. Chronic Renal Failure (kidney failure): 1 person, 5.88%
  3. Cardiac Failure: 1 person, 5.88%
  4. Angiopathy (generic term for a disease of the blood vessels): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Extraneal and Dial?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Extraneal and Dial:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Extraneal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dial:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Extraneal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dial and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on icodextrin and hexachlorophene (the active ingredients of Extraneal and Dial, respectively), and Extraneal and Dial (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: